
The FDA has approved Lipfendra, made by Merck, as the first oral PCSK9 inhibitor for lowering LDL cholesterol, a once-daily pill that cut bad cholesterol by up to 60% in clinical trials. Until now, this powerful class of cholesterol drugs was only available as an injection, and doctors say a pill option could help far more patients stick with treatment.
_and_decorated_wall_of_the_central_citadel_(2300_BCE).png%3Fwidth%3D800&w=3840&q=75)
Science · Jul 23 · L1-L4